Carta Healthcare – a health tech company aiming to harness the value of clinical data – announced today the appointment of Brent Dover as chief executive officer. Dover succeeds former CEO Matt Hollingsworth – who co-founded Carta Healthcare in 2017 and remains a board member. And in his new role, he will continue to focus on product innovation, business development, and strategic partnerships for Carta Healthcare’s market-leading solutions.
Dover brings to Carta Healthcare leadership experience in emerging companies focusing on data-driven healthcare solutions. And over the past two decades, Dover was instrumental in leading several companies through rapid growth trajectories, joining each at pivotal growth stages. Dover has most recently served as CEO at Kalderos (2022-2023), CEO at Commure (2019-2021), which in 2021 reached a $3.5 billion valuation, president of Health Catalyst (2013-2018), now a publicly traded healthcare analytics company, and president of Medicity (2007-2012), which sold to Aetna in 2011.
This year, Carta Healthcare saw substantial growth, achieving a threefold increase in revenue while expanding its healthcare system customers by 50%. Along with rapid expansion this year, Carta Healthcare expanded its product offerings and enjoyed its fourth consecutive year of 100% customer retention.
The $25 million series B funding round in March of 2023 was used to scale operations, enhance and expand the company’s products, hire key team members necessary for the company’s growth, and strengthen the company’s technological infrastructure.
KEY QUOTES:
“I am thrilled to welcome Brent to the Carta Healthcare leadership team. While his expertise in scaling health tech companies is impressive, what stands out most is Brent’s authentic dedication to our mission and his confidence in what we will be able to achieve together.”
— Matt Hollingsworth
“I am thrilled to join Matt at this critical juncture of Carta Healthcare’s journey. From the very first encounter with the team, their unwavering passion for assisting healthcare professionals and harnessing the power of real-time clinical data left an indelible impression on me. They have built an impressive company, and their strategy is working.”
— Brent Dover
